Agilent Technologies Inc.
Agilent Technologies Announces Strong Q4 2025 Financial Results and FY26 Guidance
Summary
Agilent Technologies, Inc. reported strong financial results for the fourth quarter of fiscal year 2025, with revenue of $1.86 billion, GAAP net income of $434 million, and non-GAAP net income of $452 million. The company also provided full-year 2026 revenue guidance in the range of $7.3 billion to $7.4 billion, representing growth of 5% to 7% reported and up 4% to 6% on a core basis. Additionally, Agilent furnished its press release as Exhibit 99.1, which contains detailed financial information and outlook.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement